Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 6.98
(-1.27%)
CNY 6.98
(-1.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 50 Million CNY | -29.73% |
| 2022 | 71.16 Million CNY | 19.12% |
| 2021 | 59.74 Million CNY | -3.59% |
| 2020 | 61.96 Million CNY | 444.71% |
| 2019 | -17.97 Million CNY | 91.31% |
| 2018 | -206.78 Million CNY | 41.45% |
| 2017 | -353.2 Million CNY | -378.35% |
| 2016 | -73.83 Million CNY | -3.03% |
| 2015 | -71.66 Million CNY | -60.22% |
| 2014 | -44.72 Million CNY | 27.62% |
| 2013 | -61.8 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 70.7 Million CNY | 41.39% |
| 2024 Q3 | 85.39 Million CNY | -28.14% |
| 2024 Q2 | 129.41 Million CNY | 83.04% |
| 2023 Q1 | 56.01 Million CNY | -21.29% |
| 2023 Q3 | 100.02 Million CNY | 32.7% |
| 2023 Q2 | 75.38 Million CNY | 34.57% |
| 2023 Q4 | 50 Million CNY | -50.01% |
| 2023 FY | 50 Million CNY | -29.73% |
| 2022 Q3 | 76.71 Million CNY | 8.17% |
| 2022 Q1 | 84.46 Million CNY | 41.38% |
| 2022 FY | 71.16 Million CNY | 19.12% |
| 2022 Q4 | 71.16 Million CNY | -7.23% |
| 2022 Q2 | 70.91 Million CNY | -16.04% |
| 2021 Q3 | 76.25 Million CNY | 6.41% |
| 2021 FY | 59.74 Million CNY | -3.59% |
| 2021 Q4 | 59.74 Million CNY | -21.65% |
| 2021 Q2 | 71.65 Million CNY | 16.83% |
| 2021 Q1 | 61.33 Million CNY | -1.02% |
| 2020 Q4 | 61.96 Million CNY | 5.09% |
| 2020 FY | 61.96 Million CNY | 444.71% |
| 2020 Q2 | 31.11 Million CNY | 441.17% |
| 2020 Q1 | 5.75 Million CNY | 131.99% |
| 2020 Q3 | 58.96 Million CNY | 89.5% |
| 2019 Q3 | -11.27 Million CNY | 85.08% |
| 2019 Q2 | -75.53 Million CNY | 50.64% |
| 2019 Q1 | -153.01 Million CNY | 26.0% |
| 2019 FY | -17.97 Million CNY | 91.31% |
| 2019 Q4 | -17.97 Million CNY | -59.47% |
| 2018 FY | -206.78 Million CNY | 41.45% |
| 2018 Q4 | -206.78 Million CNY | -12.21% |
| 2018 Q2 | -205.26 Million CNY | 15.34% |
| 2018 Q3 | -184.28 Million CNY | 10.22% |
| 2018 Q1 | -242.47 Million CNY | 31.35% |
| 2017 Q1 | 73.83 Million CNY | 200.0% |
| 2017 FY | -353.2 Million CNY | -378.35% |
| 2017 Q4 | -353.2 Million CNY | 2.34% |
| 2017 Q3 | -361.67 Million CNY | -361.66% |
| 2017 Q2 | -78.34 Million CNY | -206.1% |
| 2016 FY | -73.83 Million CNY | -3.03% |
| 2016 Q4 | -73.83 Million CNY | 0.0% |
| 2015 FY | -71.66 Million CNY | -60.22% |
| 2014 FY | -44.72 Million CNY | 27.62% |
| 2013 FY | -61.8 Million CNY | 0.0% |